XTalks
OCTOBER 13, 2021
In addition to timely diagnosis, there may soon be a preventative vaccine for inflammatory arthritic conditions such as rheumatoid arthritis. Researchers at the University of Toledo have developed a vaccine against inflammatory arthritis that has shown promise in animal models. The recalls affect almost half a million devices combined.
XTalks
NOVEMBER 23, 2022
Ayesha also talked about the latest positive Phase III trial data that Pfizer recently shared for its maternal RSV vaccine candidate. Hear more about the vaccine trial data, based on which an independent data monitoring committee has recommended that Pfizer file with the FDA for approval.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
SEPTEMBER 15, 2020
A vaccine developed by Swedish company Diamyd Medical has demonstrated significant treatment efficacy in a predefined genetic subgroup of individuals with type 1 diabetes in a Phase IIb clinical trial. In the trial, the vaccine was injected directly into the lymph nodes of type 1 diabetic individuals.
pharmaphorum
MARCH 7, 2022
The World Health Organization (WHO) announced the opening of a global biomanufacturing hub located in South Korea to provide training to low- and middle-income countries seeking to produce vaccines and other biologics, such as insulin and monoclonal antibodies. . of individuals in low-income countries have received their first dose.
XTalks
DECEMBER 15, 2022
The primary endpoints of DIAGNODE-3 are: preservation of endogenous insulin producing capacity measured as stimulated C-peptide; and. All participants will receive vitamin D for one month, then participants will be randomized 2:1 to receive three intralymphatic injections of Diamyd or matching placebo given one month apart.
XTalks
FEBRUARY 9, 2021
Related: Moderna’s COVID-19 Vaccine Effective Against New Variants. While type 2 diabetes is associated with inflammation, which could potentially explain the link between a COVID-19 infection and ensuing inflammatory response, the reasons for the onset of insulin-dependent type I diabetes is a bit less clear.
Pharmaceutical Technology
DECEMBER 22, 2022
The company has partnered with life sciences-focused investors Sixth Street and Royalty Pharma with an aim to bring substantial non-dilutive, low-cost capital to boost innovation and growth. Blueprint Medicines wins the Financing award this year after securing significant financing partnerships worth up to $1.25bn. Civica JAAQ Sanofi.
Expert insights. Personalized for you.
59 
Let's personalize your content